High-Risk Credit Card Processing for Peptides and Research Chemicals
Regulatory landscape, product-labeling requirements, chargeback risk, and how to structure your business to get approved for peptide processing.
Regulatory landscape, product-labeling requirements, chargeback risk, and how to structure your business to get approved for peptide processing.
Peptides sit in a regulatory gray zone: not FDA-approved for human consumption, sold "for research use only," and increasingly under FDA enforcement focus. Card networks don't have a clean MCC for the category, so files get placed under MCC 5122 (drugs/pharmacy) or 5499 (misc food) with high-risk underwriting. Add a continuity billing model and the dispute exposure compounds.
Acquirers monitor FDA warning letters and FTC enforcement against supplement and peptide brands. A warning letter in your name will get the MID frozen pending review. The protective structure most established peptide sellers use:
Peptide rates land in 4.95%–7.45% + $0.30. Rolling reserve: 10–15% held 180 days. Setup typically $0–$495. Most acquirers cap individual transactions at $500–$1,500 until processing history is established. Monthly volume caps start at $25K–$50K and step up after 90 days of clean processing.
Peptide disputes cluster around: shipping delays, product not received, and "I didn't authorize this charge" on continuity bills. The fixes:
Both explicitly prohibit "research chemicals" and unapproved drugs. Stripe will freeze on detection and hold funds 90–180 days. PayPal is the same. Self-aggregator routes (Square, Shopify Payments) are also dead-ends.
Pre-qualify with website URL, monthly volume, and processing history. We'll tell you within 24–48 hours whether the file will approve and at what terms. Underwriting itself runs 5–10 business days after a complete submission.
Join 4,200+ high-risk merchants processing with confidence. Apply now for a free, no-obligation soft review.